Kolexia
Trabaud Mary-Anne Pharmacien
Trabaud Mary-Anne
Pharmacien
Hôpital La Croix-Rousse
Lyon, France
65 Activités
15 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Hépatite Hépatite D Maladies transmissibles émergentes Hépatite B Séropositivité VIH Maladies transmissibles Breakthrough Infections

Collaborateurs

Voir plus
Icard Vinca
Icard Vinca
Hôpital La Croix-Rousse, Lyon, France
Gagnieu Marie-Claude
Gagnieu Marie-Claude
Hôpital Edouard Herriot, Lyon, France
Tardy Jean-Claude
Tardy Jean-Claude
Hôpital La Croix-Rousse, Lyon, France
Heliot-Marcelin Anne-Genevieve
Heliot-Marcelin Anne-Genevieve
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
ViiV Healthcare
13 collaboration(s)
Dernière en 2023
MSD
12 collaboration(s)
Dernière en 2023
OVERCOME
3 collaboration(s)
Dernière en 2021
MODERNA FRANCE
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
COVID-IVAC: Characterization of the Viral Genome and Humoral Immune Response in COVID-19 Vaccinated Patients With SARS-CoV-2 Infection
Essai Clinique (Hospices Civils de Lyon)   14 mars 2024
Re: First evidence of a mother-to-child transmission of an HIV-1/MO intergroup recombinant form.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   21 février 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
DORAVIR: A French national survey of people with HIV-1 treated by an antiretroviral regimen including Doravirine
HIV medicine Congress 2023   01 décembre 2023
Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.
Journal of medical virology   31 juillet 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
The Lancet. Respiratory medicine   21 février 2023
Bari-SolidAct: European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial
Essai Clinique (Oslo University Hospital)   02 février 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Critical care (London, England)   10 janvier 2023
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.
Emerging microbes & infections   27 octobre 2022
Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?
Clinical chemistry   07 juillet 2022